Palatin Technologies
PTN
#9971
Rank
โ‚ฌ29.52 M
Marketcap
17,34ย โ‚ฌ
Share price
-3.62%
Change (1 day)
2,092.36%
Change (1 year)

Palatin Technologies (PTN) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚ฌ7.33 Million

According to Palatin Technologies's latest financial reports the company's total assets are โ‚ฌ7.33 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Palatin Technologies - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-06-30โ‚ฌ10 M-39.12%
2023-06-30โ‚ฌ16.43 M-52.26%
2022-06-30โ‚ฌ34.42 M-39.35%
2021-06-30โ‚ฌ56.75 M-25.02%
2020-06-30โ‚ฌ75.69 M-17.86%
2019-06-30โ‚ฌ92.15 M176.43%
2018-06-30โ‚ฌ33.33 M-33.07%
2017-06-30โ‚ฌ49.8 M409.44%
2016-06-30โ‚ฌ9.77 M-63.07%
2015-06-30โ‚ฌ26.47 M188.61%
2014-06-30โ‚ฌ9.17 M-52.4%
2013-06-30โ‚ฌ19.26 M353.28%
2012-06-30โ‚ฌ4.25 M-70.9%
2011-06-30โ‚ฌ14.6 M47.45%
2010-06-30โ‚ฌ9.9 M6.11%
2009-06-30โ‚ฌ9.33 M-23.14%
2008-06-30โ‚ฌ12.14 M-61.85%
2007-06-30โ‚ฌ31.83 M0.67%
2006-06-30โ‚ฌ31.61 M7.31%
2005-06-30โ‚ฌ29.46 M28.89%
2004-06-30โ‚ฌ22.85 M15.07%
2003-06-30โ‚ฌ19.86 M59.5%
2002-06-30โ‚ฌ12.45 M-25.71%
2001-06-30โ‚ฌ16.76 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
MediciNova
MNOV
โ‚ฌ40.52 M 452.30%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
โ‚ฌ5.1 M-30.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚ฌ3.63 B 49,416.75%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
โ‚ฌ1.19 B 16,245.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚ฌ1.25 B 17,042.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ164.22 B 2,238,131.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
โ‚ฌ0.41 B 5,543.52%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ97.48 B 1,328,518.89%๐Ÿ‡ฌ๐Ÿ‡ง UK